VITEK 2 may deduce false susceptibility to cefixime in Staphylococcus.
Clinical Microbiology and Virology, Spirito Santo Hospital, Pescara (PE), Italy.
Vincenzo
V
Savini
Clinical Microbiology and Virology, Spirito Santo Hospital, Pescara (PE), Italy.
Carlo
C
Crescenzi
Clinical Microbiology and Virology, Spirito Santo Hospital, Pescara (PE), Italy.
Daniela
D
Astolfi
Clinical Microbiology and Virology, Spirito Santo Hospital, Pescara (PE), Italy.
Roberta
R
Marrollo
Clinical Microbiology and Virology, Spirito Santo Hospital, Pescara (PE), Italy.
Andrea
A
Balbinot
Clinical Pathology, San Liberatore Hospital, Atri (TE), Italy.
Claudio
C
D'Amario
Clinical Microbiology Laboratory, IRCCS Arcispedale Santa Maria Nuova, Reggio Emilia (RE), Italy.
Edoardo
E
Carretto
Clinical Microbiology and Virology, Spirito Santo Hospital, Pescara (PE), Italy.
Paolo
P
Fazii
Clinical Microbiology and Virology, Spirito Santo Hospital, Pescara (PE), Italy.
Domenico
D
D'Antonio
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D020682:Cefixime / Q000494:pharmacology*; D005189:False Positive Reactions; D006801:Humans; D008826:Microbial Sensitivity Tests / Q000379:methods*; D013203:Staphylococcal Infections / Q000382:microbiology; D013210:Staphylococcus / Q000187:drug effects*
D000900:Anti-Bacterial Agents; D020682:Cefixime